BE532806A - - Google Patents
Info
- Publication number
- BE532806A BE532806A BE532806DA BE532806A BE 532806 A BE532806 A BE 532806A BE 532806D A BE532806D A BE 532806DA BE 532806 A BE532806 A BE 532806A
- Authority
- BE
- Belgium
- Prior art keywords
- bis
- beta
- melting point
- fusion
- pentane
- Prior art date
Links
- -1 hydroxyalkyl halide Chemical class 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 10
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 5
- XNMQEEKYCVKGBD-UHFFFAOYSA-N 2-Butyne Chemical group CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- IAQRGUVFOMOMEM-ONEGZZNKSA-N trans-but-2-ene Chemical group C\C=C\C IAQRGUVFOMOMEM-ONEGZZNKSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000002844 melting Methods 0.000 description 21
- 230000004927 fusion Effects 0.000 description 15
- 125000004432 carbon atoms Chemical group C* 0.000 description 12
- OFBQJSOFQDEBGM-UHFFFAOYSA-N pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- 150000003141 primary amines Chemical class 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N n-heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 5
- SCVFZCLFOSHCOH-UHFFFAOYSA-M Potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- IOLCXVTUBQKXJR-UHFFFAOYSA-M Potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 4
- 125000004429 atoms Chemical group 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 125000004433 nitrogen atoms Chemical group N* 0.000 description 4
- 150000003335 secondary amines Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- TVMXDCGIABBOFY-UHFFFAOYSA-N Octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 3
- 239000001273 butane Substances 0.000 description 3
- 239000008079 hexane Substances 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- ZQDPJFUHLCOCRG-AATRIKPKSA-N (E)-hex-3-ene Chemical compound CC\C=C\CC ZQDPJFUHLCOCRG-AATRIKPKSA-N 0.000 description 2
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229940083124 ganglion-blocking antiadrenergic Secondary and tertiary amines Drugs 0.000 description 2
- CTKINSOISVBQLD-UHFFFAOYSA-N glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- LTGYTOOKQWFTQG-UHFFFAOYSA-N 4-heptoxyaniline Chemical compound CCCCCCCOC1=CC=C(N)C=C1 LTGYTOOKQWFTQG-UHFFFAOYSA-N 0.000 description 1
- QZLNSNIHXKQIIS-UHFFFAOYSA-N 4-pentoxyaniline Chemical compound CCCCCOC1=CC=C(N)C=C1 QZLNSNIHXKQIIS-UHFFFAOYSA-N 0.000 description 1
- 229960003563 Calcium Carbonate Drugs 0.000 description 1
- DIOQZVSQGTUSAI-UHFFFAOYSA-N Decane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 1
- 210000001758 Mesenteric Veins Anatomy 0.000 description 1
- BOTPCHFEHFGMIO-UHFFFAOYSA-N N-methyl-4-pentoxyaniline Chemical compound CCCCCOC1=CC=C(NC)C=C1 BOTPCHFEHFGMIO-UHFFFAOYSA-N 0.000 description 1
- BKIMMITUMNQMOS-UHFFFAOYSA-N Nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 210000003240 Portal Vein Anatomy 0.000 description 1
- 241000242680 Schistosoma mansoni Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001476 alcoholic Effects 0.000 description 1
- 150000003973 alkyl amines Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- RERZISQGOCYBPU-UHFFFAOYSA-N butane;dihydrochloride Chemical compound Cl.Cl.CCCC RERZISQGOCYBPU-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- SZDZEUWZYMEIGB-UHFFFAOYSA-N decane;dihydrochloride Chemical compound Cl.Cl.CCCCCCCCCC SZDZEUWZYMEIGB-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N ethylene glycol monomethyl ether Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- IZZOKZMGQDMCAE-XQZFLANJSA-N α-L-Rhap-(1->2)-[β-D-GlcpNAc-(1->3)]-α-L-Rhap-(1->3)-α-L-Rhap-(1->2)-[β-D-GlcpNAc-(1->3)]-α-L-Rhap Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](C)O[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)NC(C)=O)O[C@@H](C)[C@@H]1O IZZOKZMGQDMCAE-XQZFLANJSA-N 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE532806A true BE532806A (ko) |
Family
ID=164702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE532806D BE532806A (ko) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE532806A (ko) |
-
0
- BE BE532806D patent/BE532806A/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0005689B1 (fr) | Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques | |
EP0063509B1 (fr) | Nouveaux dérivés de pipérazino-2 pyrimidine, procédés pour leur préparation, médicaments les contenant et leur utilisation comme intermédiaires pour la fabrication de médicaments | |
EP0021940A1 (fr) | Nouveaux dérivés aminés du benzothiazole, leur procédé de préparation et leur application en thérapeutique | |
EP0002978B1 (fr) | Dérivés de thiazolidinedione-2,4, leur préparation et leur application en thérapeutique | |
BE532806A (ko) | ||
BE779775A (fr) | Derives de l'uree, procede pour les preparer et leurs applications | |
EP0017523B1 (fr) | Nouveaux dérivés du dithiépinno (1,4)(2,3-c)pyrrole, leur préparation et les médicaments qui les contiennent | |
CA1068270A (fr) | Diamino-2,4-bromo-5 chloro-6 pyrimidines utilisables comme medicaments et procede pour leur preparation | |
EP0223647A2 (fr) | Alkylcarboxamides de pyridylalkylamines, leurs préparations et leur utilisation en tant que médicaments | |
CA1129886A (fr) | Procede de preparation de n-alcoylamino benzophenones | |
FR2479814A1 (fr) | Phenyl alcoxy propanolamines, leur preparation et leur application en tant que medicaments | |
CH407147A (fr) | Procédé de préparation de composés antitumoraux | |
CH364508A (fr) | Procédé de préparation de phénosélénazines substituées | |
BE532805A (ko) | ||
CH610893A5 (en) | Process for the preparation of a 1,5-benzodiazocine derivative | |
FR2552086A1 (fr) | Procede pour la preparation de derives condenses d'as-triazine, produits resultants et compositions pharmaceutiques les contenant | |
FR2504141A1 (fr) | Nouveaux derives dioxazabicycliques, leur procede de preparation et leur application en therapeutique | |
FR2473512A1 (fr) | Nouveaux 2-aminomethyl-6-halogeno-phenols, leur preparation et leur application comme medicaments | |
BE579146A (ko) | ||
FR2676733A1 (fr) | Derives de phenyl-1 dihydro-1,4 hydroxy-3 oxo-4 pyridazines, leur preparation et leur application en therapeutique. | |
CH408953A (fr) | Procédé de préparation de nouveaux carbazates substitués | |
BE830870A (fr) | Derives de benzisoxazole | |
BE567876A (ko) | ||
BE837320A (fr) | Derives ethers de 3-amino-1,2-propanodiol | |
EP0000678A1 (fr) | Nouvel intermédiaire de synthèse: l'anthranilate de glycéryle et son procédé de préparation |